Previous studies revealed hMOF was overexpressed in non-small-cell lung cancer (NSCLC) as an oncogene associated with large tumor size, advanced disease stage, metastasis and led to poor prognosis with drug and radiotherapy resistance [14, 15]. This evidence concerns the gene KAT8 and neoplasm.